AH Bio Fund II, L.P. — insider trades

Stock trades AH Bio Fund II, L.P. reported on SEC Form 4 at SCTX Scribe Therapeutics, Inc., NAUT Nautilus Biotechnology, Inc..

• Jul 27, 2026: bought 333,333 shares of SCTX Scribe Therapeutics, Inc. ($5.00M)
• Jun 2, 2026: sold 5,000,000 shares of NAUT Nautilus Biotechnology, Inc. ($11.8M)